Skip to Main Content
TRC_PLH
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (380)
    • Blood Glucose Meters (3)
    • Complications (133)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (66)
    • Drug-Induced Hypo/Hyperglycemia (112)
    • Monitoring (77)
    • Natural Medicines/Supplements (4)
    • Prevention (26)
    • Treatment (228)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (12)
      • Bromocriptine (7)
      • Combination Products (10)
      • Gliptins (59)
      • Glitazones (85)
      • GLP-1 (33)
      • Incretin Enhancers/Mimetics (50)
      • Insulin (122)
      • Meglitinides (32)
      • Metformin (99)
      • SGLT2 Inhibitors (71)
      • Sulfonylureas (81)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (35)
  • Hypoglycemia (20)
  • Other (16)
  • Prediabetes (1)
  • Resources (172)
  • Thyroid Disorders (24)
136 - 150 of 228 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Patient Education: Have Diabetes? Take Care of Your Feet! April 2016
Article: Choose the U-500 Kwikpen Over U-500 Vials April 2016
Other: SGLT2 Inhibitors and Risk of Ketoacidosis and Serious UTIs February 2016
Article: Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT2s February 2016
Archive: A Note from Your Pharmacist: Avoiding the Use of High-Risk Meds in Elderly Patients January 2016
Article: Use a 1:1 Ratio When Switching from Insulin Degludec to Glargine or Detemir January 2016
Article: Consider Canaglifozin As A Cause of Fractures December 2015
Commentary: Canagliflozin (Invokana, Invokamet) Bone Fracture Risk December 2015
PL Voices: Cardiovascular Outcomes with Empagliflozin (Jardiance) November 2015
PL Voices: Insulin Analogs versus Human Insulin November 2015
Commentary: Empagliflozin and Cardiovascular Disease November 2015
Article: Reassure Patients that NPH and Regular are Safe and Effective November 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
Chart: How to Switch Insulin Products November 2015
Article: Lookout for Severe Joint Pain with Gliptins October 2015
  • « Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved